Saturday, September 07, 2013 2:48:11 PM
one piece to this puzzle and how Brigitte and/or Allergan fits into this would be Allergan, which is a known for its specialty in eye care and Peregrines Imaging PGN632 ( or other version of Bavi Imaging for eye care ) has proven as effective and safe as current SOC =
Our data show that the PS-targeting PGN632 is atleast as efficacious as Standard of Care "Zirgan" ...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=75520883
---------------------------------------------------------------
Sirion Therapeutics Announces FDA Approval of Zirgan(TM) (Ganciclovir Ophthalmic Gel) 0.15% for Herpetic Keratitis
(How many ocular herpes cases per year in just the US?)
Herpetic keratitis, an ocular disease caused by the herpes simplex virus (HSV), is a significant cause of corneal blindness and a leading indication for corneal transplantation in the US, with approximately 50,000 new and recurrent cases each year. After the initial outbreak, HSV becomes a latent infection in the trigeminal ganglion or cornea, with repeated recurrences that frequently lead to corneal scarring and ocular inflammation, increasing the risk of blindness.
http://www.prnewswire.com/news-releases/sirion-therapeutics-announces-fda-approval-of-zirgantm-ganciclovir-ophthalmic-gel-015-for-herpetic-keratitis-62188252.html
-----------------------------------------------------------------
I never really paid too much attention to Allergan / Briggitte Phan / Dr. Philip Thorpe ..etc when we heard of his passing, but again... Brigitte Phan didn't just show up on Dr. Thorpes "PAV" list for no reason and works for Allergan. So..just another possibility and depth that we have in working with Bavi and imaging and there is certainly enough cases (50,000!) on an annual basis that would make this a good fit. On top of that.... Allergan doesn't own under its own right the SOC of Zirgan as the above link shows that its from "Sirion Therapeutics". I know the oncology part of it all may be completely out of the scope of Allergan, but remember.. Allergan has always been an "ACQUISITION" type company and buy what they want.... and one never knows who will take the plunge once they see the safety and effectiveness that the Bavi anti-PS targeting platform offers.
Now the question is if Allergan "may" be behind the scenes this entire time.... how would they know about Peregrines up and coming anti-PS platform?
For one... they have Lisa Ortega that was President in the Global Clinical Supply Group and "DIRECTLY" knew one, Gerald Finken... at least on a business level that we know of ... as of now. Notice the names on this list and NOTICE how Lisa Ortega is active just 2 weeks ago so she still checks in.
http://mygcsg.com/community/members/?s=CSM
-----------------------------------------------------------------
Finally... Lisa Ortega's linkedin profile and just to confirm another point of contact at CSM in Fargo, ND.... we have Lori D. which you will notice her "recommendations" on every single category under Lisa Ortegas "skills and expertise"
http://www.linkedin.com/profile/view?id=41481114&authType=name&authToken=jXEq&trk=prof-sb-browse_map-name
----------------------------------------------------------------
All this started the day we heard about the passing of Dr. Philip Thorpe... and Brigitte Phan right up there on the top of the PAV list..... and for a very Bavi reason.
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM